BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 22484513)

  • 1. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Toxicol Sci; 2004 Jan; 77(1):19-34. PubMed ID: 14600272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of genotoxicant-modified transcriptomic responses in conventional and epigenetically stabilized primary rat hepatocytes with in vivo rat liver data.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Nov; 86(11):1703-15. PubMed ID: 23052194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models.
    Doktorova TY; Yildirimman R; Vinken M; Vilardell M; Vanhaecke T; Gmuender H; Bort R; Brolen G; Holmgren G; Li R; Chesne C; van Delft J; Kleinjans J; Castell J; Bjorquist P; Herwig R; Rogiers V
    Carcinogenesis; 2013 Jun; 34(6):1393-402. PubMed ID: 23393228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
    Ellinger-Ziegelbauer H; Gmuender H; Bandenburg A; Ahr HJ
    Mutat Res; 2008 Jan; 637(1-2):23-39. PubMed ID: 17689568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
    Uehara T; Hirode M; Ono A; Kiyosawa N; Omura K; Shimizu T; Mizukawa Y; Miyagishima T; Nagao T; Urushidani T
    Toxicology; 2008 Aug; 250(1):15-26. PubMed ID: 18619722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
    van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
    Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
    Suenaga K; Takasawa H; Watanabe T; Wako Y; Suzuki T; Hamada S; Furihata C
    Mutat Res; 2013 Feb; 751(1):73-83. PubMed ID: 23183053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of specific mRNA signatures as fingerprints for carcinogenesis in mice induced by genotoxic and nongenotoxic hepatocarcinogens.
    Kossler N; Matheis KA; Ostenfeldt N; Bach Toft D; Dhalluin S; Deschl U; Kalkuhl A
    Toxicol Sci; 2015 Feb; 143(2):277-95. PubMed ID: 25410580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds.
    Josse R; Dumont J; Fautrel A; Robin MA; Guillouzo A
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):176-87. PubMed ID: 22100608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
    Watanabe T; Suzuki T; Natsume M; Nakajima M; Narumi K; Hamada S; Sakuma T; Koeda A; Oshida K; Miyamoto Y; Maeda A; Hirayama M; Sanada H; Honda H; Ohyama W; Okada E; Fujiishi Y; Sutou S; Tadakuma A; Ishikawa Y; Kido M; Minamiguchi R; Hanahara I; Furihata C
    Mutat Res; 2012 Sep; 747(2):164-75. PubMed ID: 22634710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro - in vivo correlation of gene expression alterations induced by liver carcinogens.
    Heise T; Schug M; Storm D; Ellinger-Ziegelbauer H; Ahr HJ; Hellwig B; Rahnenfuhrer J; Ghallab A; Guenther G; Sisnaiske J; Reif R; Godoy P; Mielke H; Gundert-Remy U; Lampen A; Oberemm A; Hengstler JG
    Curr Med Chem; 2012; 19(11):1721-30. PubMed ID: 22414088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens.
    Koufaris C; Wright J; Currie RA; Gooderham NJ
    Toxicol Sci; 2012 Aug; 128(2):532-43. PubMed ID: 22584684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
    van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
    Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
    Thomas RS; O'Connell TM; Pluta L; Wolfinger RD; Yang L; Page TJ
    Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes.
    Schaap MM; Zwart EP; Wackers PF; Huijskens I; van de Water B; Breit TM; van Steeg H; Jonker MJ; Luijten M
    Arch Toxicol; 2012 Nov; 86(11):1717-27. PubMed ID: 22710402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
    Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
    Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 12 mouse marker genes in rat toxicogenomics public data, Open TG-GATEs: Discrimination of genotoxic from non-genotoxic hepatocarcinogens.
    Furihata C; Suzuki T
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Feb; 838():9-15. PubMed ID: 30678831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.
    Römer M; Eichner J; Metzger U; Templin MF; Plummer S; Ellinger-Ziegelbauer H; Zell A
    PLoS One; 2014; 9(5):e97640. PubMed ID: 24830643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.